HomeISPC • NASDAQ
iSpecimen Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.06M | -53.82% |
Operating expense | 2.04M | -52.49% |
Net income | -1.66M | 42.86% |
Net profit margin | -156.82 | -23.74% |
Earnings per share | — | — |
EBITDA | -1.57M | 46.42% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 782.56K | -69.39% |
Total assets | 6.84M | -45.31% |
Total liabilities | 5.17M | -9.23% |
Total equity | 1.67M | — |
Shares outstanding | 2.50M | — |
Price to book | 1.48 | — |
Return on assets | -50.59% | — |
Return on capital | -146.50% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.66M | 42.86% |
Cash from operations | -1.10M | 47.12% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -1.10M | -331.82% |
Free cash flow | -476.59K | 63.52% |
Previous close
$0.99
Day range
$0.99 - $1.04
Year range
$0.86 - $11.80
Market cap
2.47M USD
Avg Volume
46.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2009
Headquarters
Website
Employees
24
